<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01597765</url>
  </required_header>
  <id_info>
    <org_study_id>Si 063/2009</org_study_id>
    <nct_id>NCT01597765</nct_id>
  </id_info>
  <brief_title>Effect of Antioxidant Cocktail in Beta-thalassemia/Hb E Patients</brief_title>
  <official_title>Effect of Antioxidant Cocktail in Beta-thalassemia/Hb E Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ChaingMai University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the efficacy of antioxidant cocktails on the
      alleviation of oxidative stress and iron overload in beta-thalassemia/Hb E patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      60 cases of beta-thalassemia/Hb E patients. All patients will be diagnosed with hemoglobin
      typing of beta-thalassemia/Hb E disease and not receive blood transfusion or any treatment at
      least 3 months prior study. The study will be randomized controlled trial that designed
      before and after treatment with antioxidant cocktail. The antioxidant cocktail consists of
      vitamin E 400 IU/day, curcuminoids 500 mg/day, N-acetylcysteine 200 mg/day and deferiprone 50
      mg/kg/day. All patients will receive antioxidant cocktail daily for 12 months. The patients
      will be regularly followed up and analyzed biochemical parameters every two months during
      treatment and after withdrawal for 3 months.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Malonyldiadehyde (MDA)</measure>
    <time_frame>1 year after treatment with antioxidant cocktail.</time_frame>
    <description>Lipid peroxidation will be assayed by measuring the formation of malonyldialdehyde (MDA). The formation of MDA on red blood cell will be exposed by hydrogen peroxide. Then, MDA will be extracted by trichloroacetic acid (TCA) and will be reacted with thiobarbituric acid (TBA) in boiling condition to MDA-TBAR complex. This complex will be given pink color and measuring at 532 and 600 nm</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Thalassemia</condition>
  <arm_group>
    <arm_group_label>Curcuminoids</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The administrate curcuminoids is intervention for 30 patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin E</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The vitamin E is intervention for 30 patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>curcuminoids, N-acetylcysteine, deferiprone and vitamin E</intervention_name>
    <description>receiving curcuminoids 500 mg/day, N-acetylcysteine 200 mg/day deferiprone 50 mg/kg/day and vitamin E 400 IU/day</description>
    <arm_group_label>Curcuminoids</arm_group_label>
    <arm_group_label>Vitamin E</arm_group_label>
    <other_name>curcuminoids 500 mg brand name Anti-Ox</other_name>
    <other_name>N-acetylcysteine 200 mg brand name Mysoven</other_name>
    <other_name>deferiprone 50 mg/kg/day brand name GPO-L-ONE</other_name>
    <other_name>vitamin E 400 IU/day brand name Natural</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Curcuminoids and alpha-tocopherol</intervention_name>
    <description>group 1: receiving curcuminoids 500 mg/day, N-acetylcysteine 200 mg/day and deferiprone 50 mg/kg/day group 2: receiving vitamin E 400 IU/day, N-acetylcysteine 200 mg/day and deferiprone 50 mg/kg/day</description>
    <arm_group_label>Curcuminoids</arm_group_label>
    <arm_group_label>Vitamin E</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. age between 18-50 years

          2. hemoglobin level between 6-9 g/dL during screen visit

          3. WHO performance status grade 0-2

          4. signed in informed consents prior to the study entry.

        Exclusion Criteria:

          1. receiving iron chelator and blood transfusion.

          2. pregnancy or breastfeeding

          3. receiving other drugs except folic acid at least 30 days before study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ruchaneekorn Kalpravidh, Assoc. Prof. Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Mahidol University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Biochemistry , Faculty of Medicine Siriraj Hospital, Mahidol university</name>
      <address>
        <city>Bangkoknoi</city>
        <state>Bangkok</state>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 10, 2012</study_first_submitted>
  <study_first_submitted_qc>May 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 14, 2012</study_first_posted>
  <last_update_submitted>May 13, 2012</last_update_submitted>
  <last_update_submitted_qc>May 13, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 15, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Thalassemia</keyword>
  <keyword>Oxidative stress</keyword>
  <keyword>antioxidant cocktail</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thalassemia</mesh_term>
    <mesh_term>beta-Thalassemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin E</mesh_term>
    <mesh_term>Tocopherols</mesh_term>
    <mesh_term>Tocotrienols</mesh_term>
    <mesh_term>alpha-Tocopherol</mesh_term>
    <mesh_term>Acetylcysteine</mesh_term>
    <mesh_term>N-monoacetylcystine</mesh_term>
    <mesh_term>Antioxidants</mesh_term>
    <mesh_term>Deferiprone</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>March 27, 2014</submitted>
    <returned>April 28, 2014</returned>
    <submitted>April 10, 2015</submitted>
    <returned>April 28, 2015</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

